The

Daily

Edition

View Previous Dates

September 23, 2021

Briefing

Is the worst of the delta surge over? Why some experts are cautiously optimistic.

Why might one Covid-19 vaccine outperform another? Here's the science behind the potential 'efficacy gap.'

AHA says hospitals will lose $54B in net income this year—but that might be an underestimate

FDA just authorized booster shots for high-risk, 65+ populations. Here’s what happens next.

Is it time to stop calling surgeries 'elective'?

Around the nation: CMS releases final payer rule for the 2022 coverage year

Print All Daily Briefing Article from

 09/23/2021

Have a Question?

x

Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

X
Cookies help us improve your website experience. By using our website, you agree to our use of cookies.